Literature DB >> 24407430

Perfluorooctanoic acid exposure and thyroid disease in community and worker cohorts.

Andrea Winquist1, Kyle Steenland.   

Abstract

BACKGROUND: Perfluorooctanoic acid (PFOA) was released from a mid-Ohio River Valley chemical plant, exposing the surrounding community to PFOA for >50 years, primarily through drinking water. Toxicological studies and some previous human studies have suggested that PFOA can disrupt thyroid homeostasis. We examined the association between PFOA and thyroid disease among community members and plant workers.
METHODS: Participants completed health surveys during 2008-2011. Yearly serum PFOA concentrations were estimated for each participant starting at birth or in 1952, whichever came later. We used Cox proportional hazard models, stratified by birth year, to assess adult thyroid disease hazard in relation to time-varying yearly or cumulative (sum of yearly estimates) estimated PFOA serum concentration, controlling for sex, race, education, smoking, and alcohol use.
RESULTS: Of 32,254 participants, 3,633 reported functional thyroid disease (excluding neoplasms, congenital disease, nodules without functional changes, cysts, and unspecified type). Analyses were restricted to 2109 cases of functional thyroid disease with thyroid prescription medication use and validation through medical record review. In analyses starting at age 20 years or in 1952, thyroid disease hazard ratios across cumulative exposure quintiles were 1.00, 1.24, 1.27, 1.36, and 1.37 among women and 1.00, 1.12, 0.83, 1.01, and 1.05 among men (log-linear trend tests: P = 0.03 and P = 0.85, respectively); similar results were observed for yearly exposure. Associations were observed for hyperthyroidism and hypothyroidism among women. Some subanalyses also suggested an increased hazard of hypothyroidism among men.
CONCLUSIONS: Higher PFOA exposure was associated with incident functional thyroid disease in this large cohort with high exposure.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24407430     DOI: 10.1097/EDE.0000000000000040

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  21 in total

1.  Characterization of non-radiolabeled Thyroxine (T4) uptake in cryopreserved rat hepatocyte suspensions: Pharmacokinetic implications for PFOA and PFOS chemical exposure.

Authors:  Julian Selano; Vicki Richardson; John Washington; Chris Mazur
Journal:  Toxicol In Vitro       Date:  2019-03-28       Impact factor: 3.500

2.  Decline in perfluorooctane sulfonate and perfluorooctanoate serum concentrations in an Australian population from 2002 to 2011.

Authors:  L-M L Toms; J Thompson; A Rotander; P Hobson; A M Calafat; K Kato; X Ye; S Broomhall; F Harden; J F Mueller
Journal:  Environ Int       Date:  2014-06-27       Impact factor: 9.621

3.  Sociodemographic and behavioral determinants of serum concentrations of per- and polyfluoroalkyl substances in a community highly exposed to aqueous film-forming foam contaminants in drinking water.

Authors:  Kelsey E Barton; Anne P Starling; Christopher P Higgins; Carrie A McDonough; Antonia M Calafat; John L Adgate
Journal:  Int J Hyg Environ Health       Date:  2019-08-20       Impact factor: 5.840

4.  Effect of long- and short-chain perfluorinated compounds on cultured thyroid cells viability and response to TSH.

Authors:  L Croce; F Coperchini; M Tonacchera; M Imbriani; M Rotondi; L Chiovato
Journal:  J Endocrinol Invest       Date:  2019-05-17       Impact factor: 4.256

5.  Perfluoroalkyl substances and ovarian hormone concentrations in naturally cycling women.

Authors:  Emily S Barrett; Chongshu Chen; Sally W Thurston; Line Småstuen Haug; Azemira Sabaredzovic; Frøydis Nyborg Fjeldheim; Hanne Frydenberg; Susan F Lipson; Peter T Ellison; Inger Thune
Journal:  Fertil Steril       Date:  2015-03-04       Impact factor: 7.329

Review 6.  Thyroid disruption by perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA).

Authors:  F Coperchini; O Awwad; M Rotondi; F Santini; M Imbriani; L Chiovato
Journal:  J Endocrinol Invest       Date:  2016-11-11       Impact factor: 4.256

7.  Reliability of perfluoroalkyl substances in plasma of 100 women in two consecutive pregnancies.

Authors:  Eleni Papadopoulou; Line S Haug; Azemira Sabaredzovic; Merete Eggesbø; Matthew P Longnecker
Journal:  Environ Res       Date:  2015-05-15       Impact factor: 6.498

8.  Per- and polyfluoroalkyl substances in human serum and urine samples from a residentially exposed community.

Authors:  Rachel Rogers Worley; Susan McAfee Moore; Bruce C Tierney; Xiaoyun Ye; Antonia M Calafat; Sean Campbell; Million B Woudneh; Jeffrey Fisher
Journal:  Environ Int       Date:  2017-06-20       Impact factor: 9.621

9.  Perfluoroalkyl substances and thyroid function in older adults.

Authors:  Srishti Shrestha; Michael S Bloom; Recai Yucel; Richard F Seegal; Qian Wu; Kurunthachalam Kannan; Robert Rej; Edward F Fitzgerald
Journal:  Environ Int       Date:  2014-12-05       Impact factor: 9.621

Review 10.  Thyroid nodules and thyroid autoimmunity in the context of environmental pollution.

Authors:  Salvatore Benvenga; Alessandro Antonelli; Roberto Vita
Journal:  Rev Endocr Metab Disord       Date:  2015-12       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.